| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.6M | -40.2% |
| R&D Expense | $32.1M | -5.6% |
| SG&A Expense | $37.2M | -9.0% |
| Operating Income | -$92.7M | -31.3% |
| Net Income | -$71.1M | -22.1% |
| EPS (Basic) | -$1.60 | +28.3% |
| EPS (Diluted) | -$1.60 | +28.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.9M | -37.7% |
| Short-term Investments | $0 | -100.0% |
| Current Assets | $71.2M | -30.6% |
| Total Assets | $119.5M | -33.9% |
| Current Liabilities | $12.7M | -29.8% |
| Total Liabilities | $52.6M | -1.8% |
| Stockholders' Equity | $66.9M | -47.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$52.4M | -50.1% |
| Capital Expenditures | $12.0M | -70.9% |
| Investing Cash Flow | $30.1M | +136.7% |
| Financing Cash Flow | $779K | -99.3% |
| Free Cash Flow | -$64.4M | +15.5% |